Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma.
about
Towards Stratified Medicine in Plasma Cell MyelomaMolecular analysis of immunoglobulin genes in multiple myeloma.Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.Quantification of clonal circulating plasma cells in relapsed multiple myelomaIdentification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis.Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.Immunophenotyping in multiple myeloma and related plasma cell disorders.Future directions in the clinical management of amyloid light-chain amyloidosis.Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with RituximabHigh-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma.Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.Radioimmunodetection of human myeloma xenografts with a monoclonal antibody directed against a plasma cell specific antigen, HM1.24.Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma.Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
P2860
Q28074994-85FBD116-79D3-486D-B35A-422F86053EF7Q33604355-2553B220-5FA3-453E-B55A-C15E492093CFQ34173892-54524197-D526-4DE5-BE2D-3562D23EECA2Q34416126-93541443-4697-420E-85D6-0F221295CE78Q35552249-A0C9111C-C954-4C38-921D-D44D426F15A1Q35573416-4316FC2B-FED5-4CCF-AEEF-AF982510829BQ35849614-554229BF-1D9C-49E9-80DD-E2C0ED0E6D58Q36683750-032AC703-8154-4101-9CB1-500DFA3AC7D0Q37644812-4F67CFAF-3D71-4F00-91F1-20A63ADE702FQ37812870-D81D6C7C-6A45-4BE5-BB0D-48E1E3EFF9CFQ38172998-BAF68FEE-408C-4FF2-809B-CE8DB346BEB8Q38260684-9C697E5E-27BF-48F2-B883-AC192613A333Q38979403-40FEC890-62FF-4586-B359-45AF37D15CA4Q40140803-AAC760F9-54C0-41AD-A9BA-507E2C8DD13CQ41178761-4DCF0B70-FF96-4921-A329-FCDDE0C13AA3Q41717875-FA7171A9-436F-4EB8-8072-D33EED602676Q48017869-A308ED47-6F52-4014-8929-B741CA65FD59Q55208548-CE90E561-8B0E-4F1A-ABED-5BD72CCEE2E7Q59135626-337FF42D-0E33-4F8D-A4FD-75E518A2108F
P2860
Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Quantitation of circulating pe ...... atients with multiple myeloma.
@en
type
label
Quantitation of circulating pe ...... atients with multiple myeloma.
@en
prefLabel
Quantitation of circulating pe ...... atients with multiple myeloma.
@en
P2093
P1433
P1476
Quantitation of circulating pe ...... atients with multiple myeloma.
@en
P2093
P304
P356
10.1002/1097-0142(19930701)72:1<108::AID-CNCR2820720121>3.0.CO;2-T
P407
P577
1993-07-01T00:00:00Z